GlassScriptPhysician profile
Ronald V Hudanich
NPI 1437113404
$136,282.47
in general payments reported to CMS, 2019-2025
11 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,660 · 2020: $526 · 2021: $3,513 · 2022: $4,330 · 2023: $38K · 2024: $47K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $112K · Food and Beverage: $12K · Travel and Lodging: $1,879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $112,400.00 |
| Food and Beverage | $11,974.40 |
| Travel and Lodging | $1,878.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $135,150.40 | 2019-2025 | Mako, Aequalis, Triathlon |
| Zimmer Biomet Holdings, INC. | $534.89 | 2020-2024 | Rosa |
| Exactech, INC. | $139.15 | 2022 | |
| Janssen Pharmaceuticals, INC | $109.86 | 2021 | |
| Davol INC. | $92.90 | 2019 | |
| Smith+Nephew, INC. | $87.59 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $53.46 | 2019 | |
| Ethicon US, LLC | $45.24 | 2021-2022 | |
| Bioventus LLC | $37.90 | 2025 | Xcell |
| Horizon Therapeutics Plc | $17.58 | 2020 | |
| Curonix LLC | $13.50 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hudanich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.